P.1.006 Efficacy and safety in outpatient double-blind,placebo-controlled study comparing 30 mg and 45 mg of nemifitide versus placebo in subjects diagnosed with melon depression

Autor:	J. Freed, L. Sverdlov, Joseph J. Hlavka, S.T. Montgomery, G. Tonelli, J.P. Feiahner
Rok vydání:	2004
Předmět:	Pharmacology medicine.medical_specialty Melon business.industry Placebo-controlled study Placebo Double blind Psychiatry and Mental health Neurology Nemifitide Internal medicine medicine Physical therapy Pharmacology (medical) Neurology (clinical) business Biological Psychiatry Depression (differential diagnoses)
Zdroj:	European Neuropsychopharmacology. 14:S177
ISSN:	0924-977X
DOI:	10.1016/s0924-977x(04)80095-6
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::29790a9cb3dc44915c43a21f107326b8 https://doi.org/10.1016/s0924-977x(04)80095-6 Zobrazit plný text záznamu Full Text from ScienceDirect